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Tritiated DTLET (Tyr-D-Thr-Gly-Phe-Leu-Thr) binds with high affinity, specificity and saturability o neuroblastoma 
NI8TG2 and hybrid neuroblastoma x glioma NGI08-15 and NGI08-5 intact cells. The 6-opioid receptor density in cells 
cultured in chemically defined medium was increased about 2 times compared to that in cells cultured in 10% fetal calf 
serum. A major and a minor protein species covalently and specifically bound to p25I]azido-DTLET (Tyr-D-Thr-Gly- 
pN3Phe-Leu-Thr), photoactivatable ligand, migrated on SDS-gel electrophoresis with Mr values near 33000 and 58000, 
respectively. 
Opioid receptor; Photoaffinity ligand; Defined medium; G l electrophoresis; (Mouse neuroblastoma, NG 108-15 cell line) 
1. INTRODUCTION 
Mammal ian  brain has been shown to contain at 
least three types (t~,/~, x)  o f  opio id receptors. The 
experimental  complexity and heterogeneity of  the 
system can be reduced by using neurotumor  hybr id 
cell lines which possess specific membrane-  
associated receptors for neurotransmitters [1]. The 
neurob lastoma-g l ioma hybr id cell line NG108-15 
carries only a single type of  opio id receptor with ~- 
opio id receptor characterist ics [2]. 
Character izat ion of  the proteins carrying t~- 
binding sites in various tissues has been reported 
by several authors using selective l igands [3,4]. The 
photoact ivatable  opio id agonist az ido -DTLET  
(Tyr-D-Thr-Gly-pN3Phe-Leu-Thr)  has been found 
to be a potent and specific probe for the irreversi- 
ble labeling of  ~-opioid receptors in rat brain mem- 
branes [5,6] (Bochet et al. ,  submitted).  
The purpose of  this study was to grow 
tumorigenic ell lines of  neural  origin in various 
cell culture condit ions to enhance the number of  
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receptor sites, and to compare the use of  the t~- 
selective opio id  agonist DTLET  (Tyr-D-Thr-Gly-  
Phe-Leu-Thr)  and its photoact ivatable  iodinated 
derivative az ido -DTLET  to label the ~-opioid 
receptors of  neurob lastoma and neurob lastoma × 
gl ioma hybr id cells. We found enhanced binding in 
cells grown in serum-free medium (SFM) to a pro- 
tein whose apparent  Mr has not been previously 
reported.  
2. MATERIALS  AND METHODS 
2.1. Cell lines 
The initial stock of the mouse neuroblastoma NI8TG2 and 
rat glioma C6BU-I parent cell lines of the hybrid NGI08-15 and 
NGI08-5 cell lines, was a gift from Drs Reiser and Hamprecht 
(University of Tubingen, FRG). Cells were used between 
passages 20 and 25. The subclone NGI08-15-H2 was obtained 
by the glass-chip technique [7]. The Ca rat glioma cells were 
supplied by Dr Faivre-Bauman (Coll~ge de France, Paris, 
France). 
2.2. Cell culture conditions 
The cells were grown in Dulbecco's modified Eagle's medium 
(DMEM) (Gibco) containing 4.5 g glucose/l, supplemented 
with 3.7 g/1 sodium bicarbonate, 2 mM L-glutamine, with and 
without 10070 Myo-clone fetal calf serum (FCS) (Gibco) and 
HAT (0.1 mM hypoxanthine, 10/zM aminopterine and 16/zM 
thymidine). Cultures were maintained without any use of an- 
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tibiotics, in a humidified atmosphere of 5% CO2 and 95% air 
and subcultivated in 75 cm 2 Corning flasks at a 1:2 split ratio. 
Cells were detached mechanically from their support and not 
enzymatically with trypsin which in some cases leads to a loss 
of opioid receptors [8]. 
When ceils were grown in serum-free chemically defined 
medium, DMEM was supplemented with NCTC-135 medium 
(4*/o) (Gibco), 2 mM glutamine, 8/~g/1 sodium selenite, 4 mg/l 
insulin, 3 mg/l transferrin and 4/~g/1 epidermal growth factor 
(EGF). 
Differentiation of the cells was induced 4 days after seeding 
either by removing the FCS or EGF and transferrin, by medium 
change, or by adding 200 mM ethanol. The flask was tightly 
closed after addition of the ethanol to minimize vaporation. 
2.3. Binding assay on whole cells 
Cells at confluency were harvested by shaking them from the 
sides of the flask in the growth medium and centrifuging at 
400 x g for 8 min. The pellets were washed twice with 50 ml of 
solution DI (137 mM NaCI, 5.4 mM KC1, 0.17 mM Na2HPO4, 
5.5 mM glucose, 0.22 mM KH2PO4) and resuspended in a Tris- 
sucrose solution (0.3 M sucrose, 0.01 M Tris-HCl, pH 8.0, 
5 mM MgCI2, 0.75 M NaCI) containing protease inhibitors 
(50 mM EGTA, 5/~M leupeptin, 50/zM soybean trypsin in- 
hibitor and 0.1 mM phenylmethanesulfonyl fluoride (PMSF)), 
according to Diekmann-Gerber et al. [9]. The cell suspensions 
were kept on ice prior to the binding assay. 
The incubation (500/A total volume) was performed in 
50 mM Tris-HCl, pH 7.4, at 37°C by adding 100/~1 of cell 
suspension (3.5 x 105 cells) to 7 different concentrations (0.6, 
1.3, 2.5, 4.8, 9.4, 18, 35 nM) of [3HIDTLET (60 Ci/mmol) 
(CEA, Saclay, France). Experiments were performed in 
triplicate. The non-specific binding was determined in the 
presence of levorphanol 10 ~M final concentration i  the in- 
cubation mixture. 20 min later, the reaction was stopped by 
filtration over GF/B Whatman filters presoaked in50 mM Tris- 
HC1, pH 7.4, containing 0.1 mg/ml bovine serum albumin 
(BSA). Dry filters were counted in aquasol (NEN) in an LKB 
scintillation counter. 
2.4. Photolabeling of  the cells 
The cell suspension (5x 105 cells) in 400/LI Tris-sucrose solu- 
tion (see above) was incubated in the dark with 200 pM 
[1251]azido-DTLET (2000 Ci/mmol) for 20 min at 37°C in a 
shaking waterbath. After washing the cell pellets twice in the 
Tris-sucrose buffer, by centrifugation at 800 rpm, cells were 
UV irradiated on ice for 10 min at 254 nm with a spectroline 
UV lamp (77/~W/cm2). Radioactivity was determined using an 
LKB gamma counter. 
2.5. Membrane preparation 
Following the photoaffinity labeling of the receptors, the in- 
tact cells were incubated 30 min on ice in a hypotonic solution 
(10 mM Tris-HCl, pH 7.4, 10 mM KC1, 1.5 mM MgC12), then 
homogenized in a Dounce glass potter (about 20 strokes) and 
centrifuged 10 min at 2000 rpm at 4°C. The supernatant was 
centrifuged 1 h at 160000 × g at 4°C. The pellets were kept 
frozen at -20°C prior to SDS-polyacrylamide g l elec- 
trophoresis (SDS-PAGE) analysis. Protein concentrations were 
determined by the amidoblack technique according to Schaff- 
ner and Weissmann [10]. 
2.6. SDS-PAGE analysis 
The resolving els, linear gradient 5-12% acrylamide, were 
performed according to a modified method first described by 
O'Farrel [11]. Samples (50/A) in sample buffer (2.3% SDS, 5% 
~-mercaptoethanol, 5 M urea in 62.5 mM Tris-HCl, pH 6.8) 
were loaded on a stacking el containing 4% acrylamide. After 
migration at 15°C, gels were fixed in cold trichloroacetic a id 
(10aT0), stained with Coomassie blue R 0.25*70 in 
methanol/acetic acid/water (9:2:9, v/v), destained in 
ethanol/acetic a id/water (3:1:6, v/v), then dried on What- 
Table 1 
Specific binding of [3H]DTLET to neuroblastoma and hybrid cell lines 
Cell lines Passage Culture Kd Bmax Receptor sites/ 
no. conditions (nM) (fmol/mg prot.) cell (× 10 a) 
NGI08-15 
(n = 5) 20-25 standard 1.04 +_ 0.14 492 _+ 77 105 _+ 14 
NG 108-15 24 standard + 
200 mM EtOH 1.21 373 71 
NGI08-15 23 SFM + EGF 1.57 610 105 
NG108-15 
(n = 3) 23-24 SFM 1.81 _ 0.06 661 + 125 189 + 47 
NGI08-15-H2 4 standard 1.16 94 19 
NG 108-5 15 standard 0.54 103 27 
N 18TG2 24 standard 1.40 545 41 
C6BU- 1 28 standard ND ND ND 
C6 26 standard ND ND ND 
C6 25 SFM ND ND ND 
Values _ standard errors of the mean. EtOH, ethanol; SFM, serum-free medium; EGF, 
epidermal growth factor; ND, not detectable 
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man papei" in a BioRad slab gel dryer. Dry gels were exposed to 
Kodak X-ray film for several days at - 80°C, using intensifying 
screens (Dupont, Wilmington, DE, USA). 
3. RESULTS 
The time course of t~-opioid binding indicated 
that the maximal binding of [3H]DTLET to 
NG108-15 cells for incubation at 37°C was ob- 
served at 20 min. Longer incubations led to a 
gradual decrease in binding. 
The specific binding of [3HIDTLET was tested 
with various cell lines derived from the nervous 
system as shown in table 1. Saturable and specific 
binding was obtained in whole cells. Kd and Bmax 
values were derived from saturation experiments. 
Labeling specificity of the peptide was defined as 
labeling prevented when 10/~M of levorphanol was 
present during the binding assay. Fig.1 shows a 
typical experiment on NG108-15 cells cultured in 
standard conditions, i.e., with 10070 fetal calf 
serum in the culture medium. Specific binding sites 
for [3H]DTLET were found with the hybrid cell 
line NG108-15 originating from the fusion of the 
neuroblastoma N18TG2 and the rat glioma 
C6BU-1 with an average of 105 × 103 sites/cell. 
Culturing in serum-free medium in the presence of 
epidermal growth factor (EGF) did not alter the 
opioid affinity for the receptor nor the maximum 
binding capacity with values for Kd = 1.57 nM and 
Bmax = 610 fmol/mg protein, versus averages of 
1.04 and 492, respectively, for cells cultured in the 
presence of 10°70 fetal calf serum. The number of 
[3H]DTLET binding sites/cell increased 1.8-fold 
when the NG108-15 cells were maintained in de- 
fined medium. However, ethanol-treated cells, in 
our culture conditions, behaved like the controls in
that they did not gain receptor sites as reported by 
Charnass et at. [12]. The subclone NG108-15-H2 
had a reduced number of receptors but of the same 
affinity as the original clone NG108-15. Relatively 
few specific enkephalin binding sites were detected 
under these conditions using a sister 
neuroblastoma x glioma hybrid cell line NGI08-5. 
cLOpioid receptors were not detected on C6BU-1 or 
C6 cells. 
Iodinated azido-DTLET was used to label the ~- 
opioid receptor. Covalent binding of the 
[125I]azido-DTLET-receptor c mplex was obtain- 
ed following UV irradiation. Approx. 2070 of the 
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Fig.1. Saturation curve and Scatchard analysis for the binding 
of [3H]DTLET at concentrations between 0.6 and 35 nM to 
NGl08-15 cells at passages 23. Total binding (o), non-specific 
binding (A) determined in the presence of 10/~M levorphanol 
and specific binding (¢) are shown. In this typical experiment, 
Scatchard analysis of specific binding yielded Kd = 1.14 nM 
and Bmax = 669 pmol/mg protein. B, bound pmol x mg 
protein -~ x nM-n; B/F, ratio bound/free pmol x mg 
protein- ~. 
radioactivity of the irradiated ligand remained 
associated to the membranes after trichloroacetic 
acid precipitation. There was a good correlation 
(coefficient -- 0.95) between the [t25I]azido- 
DTLET labeling of the cells and the Bmax 
calculated from the [3HIDTLET binding to 
neuroblastoma and hybrid cell lines (fig.2). 
Fig.3 shows the results obtained when mem- 
branes labeled with [125I]azido-DTLET and UV ir- 
radiated were subjected to SDS-PAGE and 
autoradiography. Equal quantities of membrane 
proteins (about 100/~g/slot) were applied to the 
gel. The label was incorporated into several mem- 
brane components. A major species of 33 kDa and 
a minor species of 58 kDa were labeled only in the 
absence of levorphanol. Other bands of lower in- 
tensity were labeled both in the presence or absence 
of competing opiate (40, 44, 51, 72 and 100 kDa). 
The 33 kDa protein was always the major labeled 
membrane component and was comparatively 
more abundant in the cells cultured in serum-free 
medium (fig.3A, lane 4) compared to control cells 
(fig.3B, lane 2) cultured in 10070 FCS. The results 
are reproducible and the patterns are the same 
whether or not protease inhibitors were present 
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Fig.2. Correlation of cpm bound of [~251]azido-DTLET and 
Bmax obtained with [3H]DTLET for different cell lines. 
NGI08-15 (SFM) was not included in the linear regression. 
SFM, serum-free medium; EGF, epidermal growth factor. See 
section 2 for cell culture conditions. 
1 2 3 4  5 
*-33 
Fig.4. SDS-gel electrophoresis of membrane preparation from 
cells labeled with [uSI]azido-DTLET (5-12070 gradient in 
polyacrylamide). C6BU-I rat glioma cells (lane 1); N18TG2 
mouse neuroblastoma cells in the presence (lane 2) and absence 
(lane 3) of l0/~M levorphanol; NG108-15 hybrid cells (lane 4); 
NGI08-5 hybrid cells (lane 5). Numbers to the right of the 
figure are expressed in kDa. Autoradiograms after one week 
exposure. 
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Fig.3. SDS-gel electrophoresis of membrane preparation from 
NG108-15 cells labeled with [~251]azido-DTLET (5-1207o 
gradient in polyacrylamide). Cells grown in serum-free medium 
(A), and in serum-containing medium (B). Coomassie blue- 
stained gels (A, lanes 1,2; B, lane 1) and corresponding 
autoradiograms (A, lanes 3,4; B, lane 2) after one week 
exposure. Cells labeled in the absence of competing opioid 
ligand (A, lanes 2,4; B, lanes !,2) or in the presence of 
saturating concentration of levorphanol (10/~M) (A, lanes 1,3). 
Numbers to the right of the figures are expressed in kDa. 
during the preparat ion of  membranes.  Equivalent 
results were obtained with the neuroblastoma 
N18TG2 cell line (fig.4, lane 3). Compar ison be- 
tween the NG108-15 cells and the sister cell line 
NG108-5 shows a weaker signal for the band at 
33 kDa in the latter (fig.4, lanes 4 and 5, respec- 
tively). With  the C6BU-1 cells, we did not obtain 
any label at 33 kDa (fig.4, lane 1), as for the 
levorphanol - t reated neurob lastoma cells (fig.4, 
lane 2). 
4. D ISCUSSION 
Previous studies with [t25I]azido-DTLET show- 
ed that this l igand is specific for the ~-opioid recep- 
tor and binds covalently after i radiat ion to rat 
brain membrane protein fractions (Bochet et al., 
submitted).  
Our results show that all cell lines bind the 
opioid pept ide with the same aff inity but fewer 
specific sites were observed with parental  N18TG2 
and sister NG108-5 cell lines than with the 
NG108-15 cell line. No specific binding was ob- 
tained with the other parental  C6BU-1 cell line 
(table 1). The subclone NG108-15-H2 had a re- 
duced number o f  receptors, but of  the same affini- 
ty as the original clone (NG108-15), which may 
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indicate a lack of homogeneity in this cell popula- 
tion. The binding of DTLET in these cells was 
blocked by the opiate agonist levorphanol. 
Neuroblastoma x glioma hybrid cell lines main- 
tained in defined medium exhibited morphological 
changes, such as neurite extension as described by 
Bottenstein and Sato [13]. Serum removal was cor- 
related with a more differentiated morphology 
along with an increase of specific ~-receptor 
binding sites. This suggests that we were able to in- 
duce differentiation (as defined by the expression 
of binding sites) of these cells by serum removal 
and that we can manipulate the abundancy of this 
receptor subtype on this cell line in the presence of 
SFM. SFM is a known medium for inducing recep- 
tors, like the GM1 ganglioside [14], which is the 
receptor for the cholera toxin. The results obtained 
in serum-free culture conditions are in agreement 
with those of Griffin et al. [15] who obtained using 
etorphin as opiate ligand a Kd = 1.29 _+ 0.22 nM 
and Bmax = 830 _+ 44 fmol/mg protein vs a Kd = 
1.75 _+ 0.28 and Bmax = 760 _+ 88 for serum- 
cultured NG108-15 cells. 
Comparison between the tritiated probe 
[3H]DTLET and the iodinated photoactivatable 
derivative [125I]azido-DTLET showed that they 
both bind with high affinity in a specific manner to 
the same population of binding sites in these cell 
lines (fig.2). SDS-PAGE gels indicated that after 
photoirradiation, the irreversibly bound radioac- 
tivity was associated with proteins of approx. 33 
and 58 kDa (fig.3). These bands were not detec- 
table when the incubation was performed in the 
presence of levorphanol. The 58 kDa band, not 
labeled in levorphanol-treated cells, could be the 
subunit of the d~-receptor described by Klee et al. 
[16] and a polymer of the 33 kDa protein, since, 
according to Simonds et al. [4], the ~-receptor 
displays a strong tendency to aggregate. Further- 
more, the parental neuroblastoma N18TG2 cell 
line had [3I-IIDTLET binding sites (41000 
sites/cell). When the N 18TG2 membrane prepara- 
tion labeled with [t25I]azido-DTLET was subjected 
to SDS-PAGE analysis, we obtained the same 
migration pattern as for the NG108-15 cells. With 
the other parental cell line C6BU-1, there was no 
specific binding and no band at 33 kDa. This sug- 
gests strongly that proteins of an apparent Mr 
33000 for the major species and 58000 for the 
minor species (in denaturing conditions) might be 
components of the ~-opioid receptor in mouse 
neuroblastoma and hybrid mouse neuroblastoma 
rat glioma cell lines. 
Howard et al. [3] reported, using/3-[125I]endor - 
phin and bifunctional cross-linking reagents, two 
species of labeled proteins of 25 kDa and 53 kDa 
in NG108-15 cells. Simonds et al. [4] reported, in 
this cell line, a glycosylated protein with an Mr near 
58000 using the acylating agent [3H]Super-FIT. 
We have found here that we can enhance by 2-fold 
the number of d~-receptor sites/cell, and that he 
photoactivatable azido-DTLET ligand labeled 
specifically two proteins of 33 and 58 kDa. To our 
knowledge, this is the first study to show that a 
protein of 33 kDa is part of the ~;-opioid receptor 
in the mouse neuroblastoma cells and their derived 
hybrid cell lines. 
Acknowledgements: We thank Dr J. Rossier for use of 
laboratory facilities and for critical reading of the manuscript 
with Drs J.E Gairin, V.A. Liepkalns and T. Shimahara. We 
thank Drs C. Garbay-Jaureguiberry and B.P. Roques for their 
generous gift of DTLET and azido-DTLET. This work was 
supported by the CNRS. 
REFERENCES 
[l] Dawson, G., McLawhon, R.W. and Scheideler, M.A. 
(1983) in: The Mechanism of Action of Opiates and Other 
Neuroactive Agents. Neuroscience Approached Through 
Cell Culture (Pfeiffer, S.E. ed.) vol.2, pp.89-114, CRC 
Press, New York. 
[2] Chang, K.J. and Cuatrecasas, P. (1979) J. Biol. Chem. 
254, 2610-2618. 
[3] Howard, A.D., De la Baume, S., Gioannini, T.L., Hiller, 
J.M. and Simon, E.J. (1985) J. Biol. Chem. 260, 
10833-10839. 
[4] Simonds, W.F., Burke, T.R., Rice, K.C., Jacobson, A.E. 
and Klee, W.A. (1985) Proc. Natl. Acad. Sci. USA 82, 
4974-4978. 
[5] Garbay-Jaureguiberry, C., Robichon, A., Daug6, V., 
Rossignol, P. and Roques, B.P. (1984) Proc. Natl. Acad. 
Sci. USA 81, 7718-7722. 
[6] Zajac, J.-M., Rostene, W. and Roques, B.P. (1987) 
Neuropeptides 9, 295-307. 
[7] Martin, G.M. (1973) in: Tissue Culture, Methods and 
Applications (Kruse, P.F. and Patterson, M.K. eds) 
pp.264-265, Academic Press, New York. 
[8] Klee, W.A. and Nirenberg, M. (1974) Proc. Natl. Acad. 
Sci. USA 71, 3474-3477. 
[9] Diekmann Gerber, L., Stein, S., Rubistein, M., 
Wideman, J. and Udenfriend, S. (1978) Brain Res. 151, 
117-126. 
[10] Schaffner, W. and Weissmann, C. (1973) Anal. Biochem. 
56, 502-514. 
171 
Volume 233, number 1 FEBS LETTERS June 1988 
[ll] O'Farrel, P.H. 0975) J. Biol. Chem. 250, 4007-4021. 
[12] Charness, M.E., Querimit, L.A. and Diamond, L. (1986) 
J. Biol. Chem. 261, 3164-3169. 
[13] Bottenstein, J.E. and Sato, G.H. (1979) Proc. Natl. 
Acad. Sci. USA 76, 514-517. 
[14] Liepkalns, V.A., lcard-Liepkalns, C., Yates, A.J., 
Mattison, S. and Stephens, R.E. 0983) J. Lipid Res. 24, 
533-540. 
[15] Griffin, M.T., Law, P.-Y. and Loh, H.H. (1985) Brain 
Res. 360, 370-373. 
[16] Klee, W.A., Simonds, W.F., Sweat, F.W., Bruke, T.R., 
Jacobson, A.E. and Rice, K.C. (1982) FEBS Lett. 150, 
125-128. 
172 
